ResearcherIRCCS Ospedale San RaffaeleNo recent work listed
Eugenio Villa
Matched on OpenAlex author ID A5103396217. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2011: 1 paper · 2012: 2 papers · 2013: 1 paper
Papers 4
- Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. Last author DOI 10.1016/j.ejca.2013.06.041↗
- A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirub… Last author DOI 10.1007/s00280-011-1680-2↗
- Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Last author DOI 10.1245/s10434-011-2205-2↗
- Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial. Last author DOI 10.1159/000324865↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stefano Cereda · 4 shared papers, 2011–2013 · strength 0.11
- Paper Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. DOI 10.1016/j.ejca.2013.06.041↗
- Paper Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a ph… DOI 10.1159/000324865↗
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Michele Reni · 4 shared papers, 2011–2013 · strength 0.11
- Paper Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. DOI 10.1016/j.ejca.2013.06.041↗
- Paper Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a ph… DOI 10.1159/000324865↗
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Carmen Belli · 2 shared papers, 2012–2013 · strength 0.06
- Paper Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. DOI 10.1016/j.ejca.2013.06.041↗
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Giuseppe Aprile · 2 shared papers, 2012–2013 · strength 0.06
- Paper Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial. DOI 10.1016/j.ejca.2013.06.041↗
- Paper Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancrea… DOI 10.1245/s10434-011-2205-2↗
- Michele Ghidini · 2 shared papers, 2011–2012 · strength 0.05
- Paper Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a ph… DOI 10.1159/000324865↗
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Paolo Passoni · 2 shared papers, 2012 · strength 0.05
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Paper Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancrea… DOI 10.1245/s10434-011-2205-2↗
- Gianpaolo Balzano · 2 shared papers, 2012 · strength 0.05
- Paper A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, cape… DOI 10.1007/s00280-011-1680-2↗
- Paper Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancrea… DOI 10.1245/s10434-011-2205-2↗
- Andrea Mambrini · 1 shared paper, 2013 · strength 0.03
- Alessandro Passardi · 1 shared paper, 2013 · strength 0.03
- Francesca Bergamo · 1 shared paper, 2013 · strength 0.03
- Michèle Milella · 1 shared paper, 2013 · strength 0.03
- Piercarlo Saletti · 1 shared paper, 2012 · strength 0.03
- Carlo Milandri · 1 shared paper, 2012 · strength 0.03
- Nadia Gisella Di Muzio · 1 shared paper, 2012 · strength 0.03
- Claudio Doglioni · 1 shared paper, 2012 · strength 0.03
- Alessandro Zerbi · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.